BALTIMORE, MD / ACCESSWIRE / March 1, 2023 / Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has published a new research report on clinical stage biotech QSAM Biosciences, Inc. (OTCQB:QSAM), a developer of next-generation radiopharmaceutical therapy (RPT) for the treatment of cancer and other diseases. The report carries a price target. To view the new research report, along with previous reports and updates, disclosures and disclaimers, or to download the report in its entirety, please visit


Signup for Our Newsletter